Usual Interstitial Pneumonia and Lung Cancer

Area of Science:

• Pulmonology
• Oncology
• Epidemiology

Background:

• Lung cancer is a leading cause of cancer mortality globally.
• Interstitial lung diseases, especially usual interstitial pneumonia (UIP), are associated with increased lung cancer risk.
• Understanding this comorbidity is crucial for patient management.

Purpose of the Study:

• To investigate the epidemiology, clinical features, histology, and treatment outcomes of lung cancer in patients with usual interstitial pneumonia (UIP).
• To highlight the challenges in managing this dual diagnosis.

Main Methods:

• Retrospective study of patients with UIP and lung cancer from January 2016 to September 2024.
• Data collected included demographics, clinical presentation, imaging, histology, treatment, and outcomes.
• Statistical analysis performed using Epi Info version 7.2.6.0.

Main Results:

• 10 male patients (mean age 66.2 years) with UIP and lung cancer were analyzed.
• Common symptoms included cough (80%) and dyspnea (70%).
• Adenocarcinoma and squamous cell carcinoma were equally prevalent (40% each); 60% were diagnosed at Stage IV. Four patients died.

Conclusions:

• The association between UIP and lung cancer poses significant clinical and therapeutic challenges.
• Effective management requires a multidisciplinary approach to improve patient prognosis and quality of life.
• Further research is needed to develop optimal treatment protocols for this patient group.